Abstract
This review discusses the new recommendations in the 2023 European Society of Cardiology guidelines on the management of acute coronary syndrome and provides a perspective on topics specific to clinical practice in the Netherlands, including pre-treatment, antiplatelet agent strategies, the use of risk scores and logistical considerations with regard to the timing of coronary angiography.
| Original language | English |
|---|---|
| Pages (from-to) | 338-345 |
| Number of pages | 8 |
| Journal | Netherlands Heart Journal |
| Volume | 32 |
| Issue number | 10 |
| Early online date | 10 Sept 2024 |
| DOIs | |
| Publication status | Published - Oct 2024 |
Keywords
- Acute coronary syndrome
- Antiplatelet therapy
- Guidelines
- Percutaneous coronary intervention
Fingerprint
Dive into the research topics of '2023 European Society of Cardiology guidelines for the management of acute coronary syndromes: Statement of endorsement by the NVVC'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver